Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers.
Our proprietary platform technology, Eumbody System™,
enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate to optimize the immune-cell function for oncology targets.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.